A retrospective review of changes and challenges in the use of antiseizure medicines in Dravet syndrome in Norway
Abstract Objective Dravet syndrome is a developmental and epileptic encephalopathy characterized by severe and drug‐resistant seizures in early childhood, followed by developmental delay. The purpose of this study was to investigate aspects of pharmacological treatment of Norwegian patients with Dra...
Main Authors: | Katrine Heger, Caroline Lund, Margrete Larsen Burns, Marit Bjørnvold, Erik Sætre, Svein I. Johannessen, Cecilie Johannessen Landmark |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-09-01
|
Series: | Epilepsia Open |
Subjects: | |
Online Access: | https://doi.org/10.1002/epi4.12413 |
Similar Items
-
Acute effect of antiseizure drugs on background oscillations in Scn1aA1783V Dravet syndrome mouse model
by: Shir Quinn, et al.
Published: (2023-03-01) -
Efficacy and tolerability of add‐on stiripentol in real‐world clinical practice: An observational study in Dravet syndrome and non‐Dravet developmental and epileptic encephalopathies
by: Antonio Gil‐Nagel, et al.
Published: (2024-02-01) -
Neuropharmacology of Antiseizure Drugs
by: Tahir Hakami
Published: (2021-09-01) -
Fenfluramine Add-On Therapy of Dravet Syndrome
by: J Gordon Millichap
Published: (2012-08-01) -
Dravet Syndrome—The Polish Family’s Perspective Study
by: Justyna Paprocka, et al.
Published: (2021-04-01)